首页|中医药干预载脂蛋白E及其信号通路治疗冠心病的研究进展

中医药干预载脂蛋白E及其信号通路治疗冠心病的研究进展

扫码查看
综述中医药干预载脂蛋白E(Apo E)及其相关信号通路治疗冠心病的研究进展.Apo E与冠心病具有密切关系,目前西医治疗冠心病的方式主要为手术治疗及药物治疗,但均有较明显的副作用.中药可多靶点地调控NF-κB、NLRP3炎症小体、eNOS/NO、LXRα-ABCA1-ApoA-I等信号通路,发挥抗炎、调节脂质代谢、稳定斑块、减轻血管内皮功能障碍、调节胆固醇逆转运的作用,从而达到治疗冠心病的目的.
Research Progress on Traditional Chinese Medicine Intervention of Apolipoprotein E and Its Signaling Pathway in the Treatment of Coronary Heart Disease
This article reviews the research progress of traditional Chinese medicine intervention on apolipoprotein E(ApoE)and its related signaling pathways in the treatment of coronary heart disease.Apo E is closely related to coronary heart disease.Currently,Western medicine mainly treats coronary heart disease through surgical treatment and drug therapy,but both have significant side effects.Chinese herbal medicines can modulate NF-κB,NLRP3 inflammatory vesicles,eNOS/NO,LXRα-ABCA1-ApoA-I and other signaling pathways in a multi-targeted manner to exert anti-inflammatory,modulating lipid metabolism,stabilizing plaque,reducing vascular endothelial dysfunction,and regulating cholesterol reversal transport to treat coronary heart disease.

coronary heart diseaseApo Esignaling pathwaytraditional Chinese medicinereview

李炯侠、杨宇婷、白杨、陈亮亮、卫培峰、刘丹、焦晨莉、程玥

展开 >

三二○—医院,陕西 汉中 723000

陕西中医药大学药学院,陕西 咸阳 712046

冠心病 载脂蛋白E 信号通路 中药 综述

陕西省中医药管理局"双链融合"中青年科研创新团队项目2022年陕西省特支计划人才计划项目

2022-SLRH-YQ-008

2024

中医药导报
湖南省中医药学会 湖南省中医管理局

中医药导报

CSTPCD
影响因子:0.952
ISSN:1672-951X
年,卷(期):2024.30(1)
  • 75